vs
Steris（STE）与伟世通（VC）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是伟世通的1.6倍（$1.5B vs $948.0M），Steris净利率更高（12.9% vs 7.8%，领先5.1%），Steris同比增速更快（9.2% vs 1.0%），过去两年Steris的营收复合增速更高（15.8% vs 0.8%）
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
伟世通是一家总部位于美国密歇根州范布伦镇区的全球性汽车电子供应商，业务涵盖汽车座舱电子产品、车联网服务以及电动化相关产品的设计、研发与制造，客户几乎覆盖全球所有主流汽车制造商。
STE vs VC — 直观对比
营收规模更大
STE
是对方的1.6倍
$948.0M
营收增速更快
STE
高出8.2%
1.0%
净利率更高
STE
高出5.1%
7.8%
两年增速更快
STE
近两年复合增速
0.8%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $948.0M |
| 净利润 | $192.9M | $74.0M |
| 毛利率 | 43.8% | 12.9% |
| 营业利润率 | 18.3% | 6.9% |
| 净利率 | 12.9% | 7.8% |
| 营收同比 | 9.2% | 1.0% |
| 净利润同比 | 11.2% | -40.8% |
| 每股收益（稀释后） | $1.96 | $2.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收STEVC
| Q4 25 | $1.5B | $948.0M | ||
| Q3 25 | $1.5B | $917.0M | ||
| Q2 25 | $1.4B | $969.0M | ||
| Q1 25 | $1.5B | $934.0M | ||
| Q4 24 | $1.4B | $939.0M | ||
| Q3 24 | $1.3B | $980.0M | ||
| Q2 24 | $1.3B | $1.0B | ||
| Q1 24 | $1.1B | $933.0M |
净利润STEVC
| Q4 25 | $192.9M | $74.0M | ||
| Q3 25 | $191.9M | $-11.0M | ||
| Q2 25 | $177.4M | $71.0M | ||
| Q1 25 | $145.7M | $67.0M | ||
| Q4 24 | $173.5M | $125.0M | ||
| Q3 24 | $150.0M | $40.0M | ||
| Q2 24 | $145.4M | $83.0M | ||
| Q1 24 | $-1.4M | $48.0M |
毛利率STEVC
| Q4 25 | 43.8% | 12.9% | ||
| Q3 25 | 44.2% | 14.3% | ||
| Q2 25 | 45.1% | 14.6% | ||
| Q1 25 | 43.3% | 14.8% | ||
| Q4 24 | 44.5% | 14.3% | ||
| Q3 24 | 43.6% | 13.4% | ||
| Q2 24 | 44.7% | 14.5% | ||
| Q1 24 | 40.2% | 12.8% |
营业利润率STEVC
| Q4 25 | 18.3% | 6.9% | ||
| Q3 25 | 18.2% | 8.8% | ||
| Q2 25 | 17.7% | 10.0% | ||
| Q1 25 | 14.6% | 10.2% | ||
| Q4 24 | 17.9% | 8.9% | ||
| Q3 24 | 16.5% | 5.2% | ||
| Q2 24 | 14.5% | 9.9% | ||
| Q1 24 | 22.0% | 6.8% |
净利率STEVC
| Q4 25 | 12.9% | 7.8% | ||
| Q3 25 | 13.1% | -1.2% | ||
| Q2 25 | 12.8% | 7.3% | ||
| Q1 25 | 9.8% | 7.2% | ||
| Q4 24 | 12.7% | 13.3% | ||
| Q3 24 | 11.3% | 4.1% | ||
| Q2 24 | 11.4% | 8.2% | ||
| Q1 24 | -0.1% | 5.1% |
每股收益（稀释后）STEVC
| Q4 25 | $1.96 | $2.67 | ||
| Q3 25 | $1.94 | $-0.40 | ||
| Q2 25 | $1.79 | $2.57 | ||
| Q1 25 | $1.48 | $2.44 | ||
| Q4 24 | $1.75 | $4.50 | ||
| Q3 24 | $1.51 | $1.43 | ||
| Q2 24 | $1.46 | $2.97 | ||
| Q1 24 | $-0.02 | $1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $423.7M | $771.0M |
| 总债务越低越好 | $1.9B | — |
| 股东权益账面价值 | $7.2B | $1.6B |
| 总资产 | $10.6B | $3.4B |
| 负债/权益比越低杠杆越低 | 0.27× | — |
8季度趋势，按日历期对齐
现金及短期投资STEVC
| Q4 25 | $423.7M | $771.0M | ||
| Q3 25 | $319.2M | $762.0M | ||
| Q2 25 | $279.7M | $668.0M | ||
| Q1 25 | $171.7M | $655.0M | ||
| Q4 24 | $155.2M | $623.0M | ||
| Q3 24 | $172.2M | $550.0M | ||
| Q2 24 | $198.3M | $505.0M | ||
| Q1 24 | $207.0M | $504.0M |
总债务STEVC
| Q4 25 | $1.9B | — | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.2B | — | ||
| Q2 24 | $2.2B | — | ||
| Q1 24 | $3.1B | — |
股东权益STEVC
| Q4 25 | $7.2B | $1.6B | ||
| Q3 25 | $7.0B | $1.5B | ||
| Q2 25 | $7.0B | $1.5B | ||
| Q1 25 | $6.6B | $1.4B | ||
| Q4 24 | $6.4B | $1.3B | ||
| Q3 24 | $6.6B | $1.3B | ||
| Q2 24 | $6.4B | $1.2B | ||
| Q1 24 | $6.3B | $1.1B |
总资产STEVC
| Q4 25 | $10.6B | $3.4B | ||
| Q3 25 | $10.4B | $3.3B | ||
| Q2 25 | $10.4B | $3.3B | ||
| Q1 25 | $10.1B | $3.1B | ||
| Q4 24 | $10.0B | $3.0B | ||
| Q3 24 | $10.2B | $3.0B | ||
| Q2 24 | $10.1B | $2.8B | ||
| Q1 24 | $11.1B | $2.8B |
负债/权益比STEVC
| Q4 25 | 0.27× | — | ||
| Q3 25 | 0.27× | — | ||
| Q2 25 | 0.27× | — | ||
| Q1 25 | 0.29× | — | ||
| Q4 24 | 0.32× | — | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $298.2M | $118.0M |
| 自由现金流经营现金流 - 资本支出 | $199.5M | — |
| 自由现金流率自由现金流/营收 | 13.3% | — |
| 资本支出强度资本支出/营收 | 6.6% | — |
| 现金转化率经营现金流/净利润 | 1.55× | 1.59× |
| 过去12个月自由现金流最近4个季度 | $917.1M | — |
8季度趋势，按日历期对齐
经营现金流STEVC
| Q4 25 | $298.2M | $118.0M | ||
| Q3 25 | $287.8M | $127.0M | ||
| Q2 25 | $420.0M | $95.0M | ||
| Q1 25 | $260.8M | $70.0M | ||
| Q4 24 | $332.8M | $203.0M | ||
| Q3 24 | $250.7M | $98.0M | ||
| Q2 24 | $303.7M | $57.0M | ||
| Q1 24 | $254.8M | $69.0M |
自由现金流STEVC
| Q4 25 | $199.5M | — | ||
| Q3 25 | $201.3M | — | ||
| Q2 25 | $326.4M | — | ||
| Q1 25 | $189.9M | — | ||
| Q4 24 | $243.6M | — | ||
| Q3 24 | $148.8M | — | ||
| Q2 24 | $195.7M | — | ||
| Q1 24 | $163.3M | — |
自由现金流率STEVC
| Q4 25 | 13.3% | — | ||
| Q3 25 | 13.8% | — | ||
| Q2 25 | 23.5% | — | ||
| Q1 25 | 12.8% | — | ||
| Q4 24 | 17.8% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 15.3% | — | ||
| Q1 24 | 14.6% | — |
资本支出强度STEVC
| Q4 25 | 6.6% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 6.7% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 8.4% | — | ||
| Q1 24 | 8.2% | — |
现金转化率STEVC
| Q4 25 | 1.55× | 1.59× | ||
| Q3 25 | 1.50× | — | ||
| Q2 25 | 2.37× | 1.34× | ||
| Q1 25 | 1.79× | 1.04× | ||
| Q4 24 | 1.92× | 1.62× | ||
| Q3 24 | 1.67× | 2.45× | ||
| Q2 24 | 2.09× | 0.69× | ||
| Q1 24 | — | 1.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
VC
| Audioandinfotainment | $508.0M | 54% |
| Informationdisplays | $428.0M | 45% |
